Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MIRIKIZUMAB-MRKZ Cause Maternal exposure during pregnancy? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Maternal exposure during pregnancy have been filed in association with MIRIKIZUMAB-MRKZ. This represents 2.8% of all adverse event reports for MIRIKIZUMAB-MRKZ.

16
Reports of Maternal exposure during pregnancy with MIRIKIZUMAB-MRKZ
2.8%
of all MIRIKIZUMAB-MRKZ reports
0
Deaths
1
Hospitalizations

How Dangerous Is Maternal exposure during pregnancy From MIRIKIZUMAB-MRKZ?

Of the 16 reports, 1 (6.3%) required hospitalization.

Is Maternal exposure during pregnancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MIRIKIZUMAB-MRKZ. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does MIRIKIZUMAB-MRKZ Cause?

Colitis ulcerative (94) Injection site pain (71) Drug ineffective (47) Arthralgia (22) Rash (21) Diarrhoea (20) Headache (19) Incorrect dose administered (17) Dizziness (15) Haematochezia (15)

What Other Drugs Cause Maternal exposure during pregnancy?

CERTOLIZUMAB PEGOL (9,013) ADALIMUMAB (7,518) PREDNISONE (6,587) METHOTREXATE (6,223) RITUXIMAB (6,093) INFLIXIMAB (6,061) HYDROXYCHLOROQUINE (5,809) FOLIC ACID (5,768) TOCILIZUMAB (5,737) LEFLUNOMIDE (5,643)

Which MIRIKIZUMAB-MRKZ Alternatives Have Lower Maternal exposure during pregnancy Risk?

MIRIKIZUMAB-MRKZ vs MIRTAZAPINE MIRIKIZUMAB-MRKZ vs MIRVETUXIMAB SORAVTANSINE-GYNX MIRIKIZUMAB-MRKZ vs MISOPROSTOL MIRIKIZUMAB-MRKZ vs MITAPIVAT MIRIKIZUMAB-MRKZ vs MITOMYCIN

Related Pages

MIRIKIZUMAB-MRKZ Full Profile All Maternal exposure during pregnancy Reports All Drugs Causing Maternal exposure during pregnancy MIRIKIZUMAB-MRKZ Demographics